Last reviewed · How we verify
CN54gp140 glycoprotein-hsp70 conjugate vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
CN54gp140 glycoprotein-hsp70 conjugate vaccine (CN54gp140 glycoprotein-hsp70 conjugate vaccine) — St George's, University of London.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| CN54gp140 glycoprotein-hsp70 conjugate vaccine TARGET | CN54gp140 glycoprotein-hsp70 conjugate vaccine | St George's, University of London | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- CN54gp140 glycoprotein-hsp70 conjugate vaccine CI watch — RSS
- CN54gp140 glycoprotein-hsp70 conjugate vaccine CI watch — Atom
- CN54gp140 glycoprotein-hsp70 conjugate vaccine CI watch — JSON
- CN54gp140 glycoprotein-hsp70 conjugate vaccine alone — RSS
Cite this brief
Drug Landscape (2026). CN54gp140 glycoprotein-hsp70 conjugate vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/cn54gp140-glycoprotein-hsp70-conjugate-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab